Commissioning recommendations for medical retinal vascular medicines following the national procurement for anti-vascular endothelial growth factors (VEGFs) and intravitreal steroid implants

Document first published:
Page updated:
Topic:
, ,
Publication type:

Updated commissioning recommendations for licensed intravitreal anti-VEGF and corticosteroid treatments in England for medical retinal conditions.

Link

Commissioning recommendations for medical retinal vascular medicines following the national procurement for anti-vascular endothelial growth factors (VEGFs) and intravitreal steroid implants

Commissioning recommendations for medical retinal vascular medicines following the national procurement for anti-vascular endothelial growth factors (VEGFs) and intravitreal steroid implants

NHS England is not responsible for content on external websites.

Summary

Version 3 (accessible content), updated 11 March 2023.

Document

Commissioning recommendations for medical retinal vascular medicines following the national procurement for anti-vascular endothelial growth factors (VEGFs) and intravitreal steroid implants

Commissioning recommendations for medical retinal vascular medicines following the national procurement for anti-vascular endothelial growth factors (VEGFs) and intravitreal steroid implants

  • PDF
  • 603 KB

Summary

Version 3 (PDF format), updated 11 March 2023.